A British Nobel-winning virologist has launched a programme to develop the world’s first hepatitis C vaccine after joining a university in Hong Kong, tapping the city’s research funding, access to Chinese strains of the virus and partnerships with mainland drug makers. Sir Michael Houghton, who won the 2020 Nobel Prize in Physiology or Medicine for the co-discovery of the hepatitis C virus, said he joined Baptist University after more than four decades in North America, as the United States and...